This story has been updated from a previous version.

NEW YORK, April 11 – Incyte Genomics said Wednesday it had licensed two patents to Merck that will allow the pharmaceutical company to manufacture microarrays using a patented non-PCR method for RNA amplification.

The patents, numbers 5,716,785 and 5,891,636, cover the use of a non-PCR-based RNA amplification technology, allowing researchers to create gene expression information by linearly increasing RNA samples from cellular mRNA.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.